Phase II study of individualized sunitinib (SUN) as first-line therapy for metastatic renal cell cancer: Pharmacokinetic data Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Bjarnason, GA
  • Knox, J
  • Kollmannsberger, CK
  • Soulieres, D
  • Ernst, DS
  • Zalewski, P
  • Canil, CM
  • Winquist, E
  • Hotte, Sebastien
  • North, SA
  • Heng, DYC
  • Macfarlane, RJ
  • Venner, PM
  • Kapoor, Anil
  • Hansen, AR
  • Czaykowski, P
  • Boyd, B
  • Wang, L
  • Basappa, NS

publication date

  • September 1, 2017